Sublingual vs. Capsule Absorption: What The Claim Actually Means
GlycoBloom's central differentiator is its sublingual liquid delivery, marketed as 3 times faster-absorbing than capsules.
Understanding the genuine pharmacological basis for this claim, and its limits, helps you weigh it appropriately as a buyer.
The genuine basis for faster sublingual absorption
Sublingual delivery (placing a substance under the tongue) allows certain compounds to be absorbed directly through the mucous membranes into the bloodstream, bypassing the digestive system and first-pass liver metabolism that capsules must go through. This is a genuine pharmacological mechanism used for several medications, not a marketing invention.
Why the specific multiplier is harder to verify
Whether a given sublingual formula achieves exactly 3 times faster absorption depends heavily on the specific compounds involved, their molecular size, and formulation details. We were not able to locate independent testing of this specific figure for GlycoBloom's formula. This does not mean the underlying mechanism is false, but the precise number is a brand claim rather than an independently verified one.
What this means practically
Faster absorption onset does not necessarily mean a larger or more complete overall effect — it can simply mean the same ingredients reach the bloodstream sooner. For a supplement aimed at ongoing blood sugar support rather than acute symptom relief, the practical difference between formats may matter less than the ingredients and their (undisclosed) doses.
Applying this to GlycoBloom
See what GlycoBloom is for the full picture, or our complete review for how this weighs against the formula's ingredients overall.
